DoD Mandatory Declassification Review (MDR) Program; Correction, 745 [2011-33857]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Rules and Regulations
PART 530—EXTRALABEL DRUG USE
IN ANIMALS
1. The authority citation for 21 CFR
part 530 continues to read as follows:
■
Authority: 15 U.S.C. 1453, 1454, 1455; 21
U.S.C. 321, 331, 351, 352, 353, 355, 357,
360b, 371, 379e.
2. In § 530.41, add paragraph (a)(13) to
read as follows:
■
Department of Defense discovered that
paragraph § 222.5(f) in the third column
of page 80746 should have read
§ 222.5(j).
Correction
In the final rule (FR Doc. 2011–33104)
published on December 27, 2011 (76 FR
80744–80747), make the following
correction:
§ 222.5
§ 530.41 Drugs prohibited for extralabel
use in animals.
(a) * * *
(13) Cephalosporins (not including
cephapirin) in cattle, swine, chickens,
or turkeys:
(i) For disease prevention purposes;
(ii) At unapproved doses, frequencies,
durations, or routes of administration;
or
(iii) If the drug is not approved for
that species and production class.
*
*
*
*
*
[Corrected]
On page 80746, in § 222.5, in the third
column, in the first line of the third
paragraph, ‘‘(f) MDR Appeals.’’ should
read ‘‘(j) MDR Appeals.’’.
Dated: December 30, 2011.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2011–33857 Filed 1–5–12; 8:45 am]
BILLING CODE 5001–06–P
ENVIRONMENTAL PROTECTION
AGENCY
Dated: November 23, 2011.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
40 CFR Part 52
[FR Doc. 2012–35 Filed 1–4–12; 11:15 am]
BILLING CODE 4160–01–P
[EPA–R09–OAR–2011–0547; FRL–9480–1]
DEPARTMENT OF DEFENSE
Office of the Secretary
Revisions to the California State
Implementation Plan, San Joaquin
Valley Unified Air Pollution Control
District (SJVUAPCD)
[DOD–2010–OS–0043; RIN 0790–AI62]
Correction
32 CFR Part 222
DoD Mandatory Declassification
Review (MDR) Program; Correction
Department of Defense.
Final rule; correction.
AGENCY:
ACTION:
On December 27, 2011 (76 FR
80744–80747), Department of Defense
published a final rule titled DoD
Mandatory Declassification Review
(MDR) Program, which assigns
responsibilities and provides
procedures for members of the public to
request a declassification review of
information classified under the
provisions of Executive Order 13526, or
predecessor orders. This rule corrects a
paragraph identification error in the
regulations.
SUMMARY:
This correction is effective
January 26, 2012.
In rule document 2011–33660
appearing on pages 214–217 in the issue
of Wednesday, January 4, 2012, make
the following corrections:
(1) On page 214, in the second
column, in the DATES section, in the
second line, ‘‘February 3, 2011’’ should
read ‘‘February 3, 2012’’.
(2) On page 217, in the first column,
in the last paragraph, in the fifth line,
‘‘March 7, 2011’’ should read ‘‘March 5,
2012’’.
[FR Doc. C1–2011–33660 Filed 1–5–12; 8:45 am]
BILLING CODE 1505–01–D
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2010–0944; FRL–9330–4]
pmangrum on DSK3VPTVN1PROD with RULES
DATES:
FOR FURTHER INFORMATION CONTACT:
Patricia Toppings, (571) 372–0485.
On
December 27, 2011, Department of
Defense published a final rule titled
DoD Mandatory Declassification Review
(MDR) Program. Subsequent to the
publication of that final rule,
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
14:39 Jan 05, 2012
Jkt 226001
Bacillus Amyloliquefaciens Strain
D747; Exemption From the
Requirement of a Tolerance
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes an
exemption from the requirement of a
SUMMARY:
PO 00000
Frm 00017
Fmt 4700
Sfmt 4700
745
tolerance for residues of the Bacillus
amyloliquefaciens strain D747 (formerly
known as Bacillus subtilis variant
amyloliquefaciens strain D747) in or on
all food commodities when used in
accordance with good agricultural
practices. Certis USA LLC submitted a
petition to EPA under the Federal Food,
Drug, and Cosmetic Act (FFDCA),
requesting an exemption from the
requirement of a tolerance. This
regulation eliminates the need to
establish a maximum permissible level
for residues of Bacillus
amyloliquefaciens strain D747 (formerly
known as Bacillus subtilis variant
amyloliquefaciens strain D747).
DATES: This regulation is effective
January 6, 2012. Objections and requests
for hearings must be received on or
before March 6, 2012, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
ADDRESSES: EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2010–0944. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information the disclosure
of which is restricted by statute. Certain
other material, such as copyrighted
material, is not made available via the
Internet and will be publicly available
only in hard copy form. Publicly
available docket materials are available
in the electronic docket at https://
www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Susanne Cerrelli, Biopesticides and
Pollution Prevention Division (7511P),
Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460–0001; telephone number:
(703) 308–8077; email address:
cerrelli.susanne@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
E:\FR\FM\06JAR1.SGM
06JAR1
]]>Agencies
[Federal Register Volume 77, Number 4 (Friday, January 6, 2012)]
[Rules and Regulations]
[Page 745]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33857]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
[DOD-2010-OS-0043; RIN 0790-AI62]
32 CFR Part 222
DoD Mandatory Declassification Review (MDR) Program; Correction
AGENCY: Department of Defense.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: On December 27, 2011 (76 FR 80744-80747), Department of
Defense published a final rule titled DoD Mandatory Declassification
Review (MDR) Program, which assigns responsibilities and provides
procedures for members of the public to request a declassification
review of information classified under the provisions of Executive
Order 13526, or predecessor orders. This rule corrects a paragraph
identification error in the regulations.
DATES: This correction is effective January 26, 2012.
FOR FURTHER INFORMATION CONTACT: Patricia Toppings, (571) 372-0485.
SUPPLEMENTARY INFORMATION: On December 27, 2011, Department of Defense
published a final rule titled DoD Mandatory Declassification Review
(MDR) Program. Subsequent to the publication of that final rule,
Department of Defense discovered that paragraph Sec. 222.5(f) in the
third column of page 80746 should have read Sec. 222.5(j).
Correction
In the final rule (FR Doc. 2011-33104) published on December 27,
2011 (76 FR 80744-80747), make the following correction:
Sec. 222.5 [Corrected]
On page 80746, in Sec. 222.5, in the third column, in the first
line of the third paragraph, ``(f) MDR Appeals.'' should read ``(j) MDR
Appeals.''.
Dated: December 30, 2011.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2011-33857 Filed 1-5-12; 8:45 am]
BILLING CODE 5001-06-P
